Global Benign Prostatic Hyperplasia Testing Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 Urinalysis
1.4.3 Prostate-Specific Antigen (PSA) Blood Test
1.4.4 Urodynamic Test
1.4.5 Cystoscopy
1.5 Market by Application
1.5.1 Global Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Clinics
1.5.5 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Benign Prostatic Hyperplasia Testing Market Size
2.2 Benign Prostatic Hyperplasia Testing Growth Trends by Regions
2.2.1 Benign Prostatic Hyperplasia Testing Market Size by Regions (2014-2025)
2.2.2 Benign Prostatic Hyperplasia Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Benign Prostatic Hyperplasia Testing Market Size by Manufacturers
3.1.1 Global Benign Prostatic Hyperplasia Testing Revenue by Manufacturers (2014-2019)
3.1.2 Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio (CR5 and HHI)
3.2 Benign Prostatic Hyperplasia Testing Key Players Head office and Area Served
3.3 Key Players Benign Prostatic Hyperplasia Testing Product/Solution/Service
3.4 Date of Enter into Benign Prostatic Hyperplasia Testing Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019)
4.2 Global Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019)
5 United States
5.1 United States Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
5.2 Benign Prostatic Hyperplasia Testing Key Players in United States
5.3 United States Benign Prostatic Hyperplasia Testing Market Size by Type
5.4 United States Benign Prostatic Hyperplasia Testing Market Size by Application
6 Europe
6.1 Europe Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
6.2 Benign Prostatic Hyperplasia Testing Key Players in Europe
6.3 Europe Benign Prostatic Hyperplasia Testing Market Size by Type
6.4 Europe Benign Prostatic Hyperplasia Testing Market Size by Application
7 China
7.1 China Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
7.2 Benign Prostatic Hyperplasia Testing Key Players in China
7.3 China Benign Prostatic Hyperplasia Testing Market Size by Type
7.4 China Benign Prostatic Hyperplasia Testing Market Size by Application
8 Japan
8.1 Japan Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
8.2 Benign Prostatic Hyperplasia Testing Key Players in Japan
8.3 Japan Benign Prostatic Hyperplasia Testing Market Size by Type
8.4 Japan Benign Prostatic Hyperplasia Testing Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
9.2 Benign Prostatic Hyperplasia Testing Key Players in Southeast Asia
9.3 Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Type
9.4 Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Application
10 India
10.1 India Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
10.2 Benign Prostatic Hyperplasia Testing Key Players in India
10.3 India Benign Prostatic Hyperplasia Testing Market Size by Type
10.4 India Benign Prostatic Hyperplasia Testing Market Size by Application
11 Central & South America
11.1 Central & South America Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
11.2 Benign Prostatic Hyperplasia Testing Key Players in Central & South America
11.3 Central & South America Benign Prostatic Hyperplasia Testing Market Size by Type
11.4 Central & South America Benign Prostatic Hyperplasia Testing Market Size by Application
12 International Players Profiles
12.1 AEternaZentaris
12.1.1 AEternaZentaris Company Details
12.1.2 Company Description and Business Overview
12.1.3 Benign Prostatic Hyperplasia Testing Introduction
12.1.4 AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.1.5 AEternaZentaris Recent Development
12.2 Astellas Pharma
12.2.1 Astellas Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Benign Prostatic Hyperplasia Testing Introduction
12.2.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.2.5 Astellas Pharma Recent Development
12.3 Eli Lilly and Company
12.3.1 Eli Lilly and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Benign Prostatic Hyperplasia Testing Introduction
12.3.4 Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.3.5 Eli Lilly and Company Recent Development
12.4 IntelGenx Technologies Corp
12.4.1 IntelGenx Technologies Corp Company Details
12.4.2 Company Description and Business Overview
12.4.3 Benign Prostatic Hyperplasia Testing Introduction
12.4.4 IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.4.5 IntelGenx Technologies Corp Recent Development
12.5 Nymox Pharmaceutical Corporation
12.5.1 Nymox Pharmaceutical Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Benign Prostatic Hyperplasia Testing Introduction
12.5.4 Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.5.5 Nymox Pharmaceutical Corporation Recent Development
12.6 Protox Therapeutics
12.6.1 Protox Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Benign Prostatic Hyperplasia Testing Introduction
12.6.4 Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.6.5 Protox Therapeutics Recent Development
12.7 Quest PharmaTech
12.7.1 Quest PharmaTech Company Details
12.7.2 Company Description and Business Overview
12.7.3 Benign Prostatic Hyperplasia Testing Introduction
12.7.4 Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.7.5 Quest PharmaTech Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and FiguresTable Benign Prostatic Hyperplasia Testing Key Market Segments
Table Key Players Benign Prostatic Hyperplasia Testing Covered
Table Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Benign Prostatic Hyperplasia Testing Market Size Market Share by Type 2014-2025
Figure Urinalysis Figures
Table Key Players of Urinalysis
Figure Prostate-Specific Antigen (PSA) Blood Test Figures
Table Key Players of Prostate-Specific Antigen (PSA) Blood Test
Figure Urodynamic Test Figures
Table Key Players of Urodynamic Test
Figure Cystoscopy Figures
Table Key Players of Cystoscopy
Table Global Benign Prostatic Hyperplasia Testing Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Diagnostic Centers Case Studies
Figure Clinics Case Studies
Figure Research Institutes Case Studies
Figure Benign Prostatic Hyperplasia Testing Report Years Considered
Table Global Benign Prostatic Hyperplasia Testing Market Size 2014-2025 (Million US$)
Figure Global Benign Prostatic Hyperplasia Testing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Size by Regions 2014-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Size by Regions 2014-2019 (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Share by Regions 2014-2019
Figure Global Benign Prostatic Hyperplasia Testing Market Share by Regions 2014-2019
Figure Global Benign Prostatic Hyperplasia Testing Market Share by Regions 2019
Table Market Top Trends
Table Global Benign Prostatic Hyperplasia Testing Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Share by Manufacturers (2014-2019)
Figure Global Benign Prostatic Hyperplasia Testing Market Share by Manufacturers in 2018
Table Global Benign Prostatic Hyperplasia Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Benign Prostatic Hyperplasia Testing Product/Solution/Service
Table Date of Enter into Benign Prostatic Hyperplasia Testing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Size Share by Type (2014-2019)
Figure Global Benign Prostatic Hyperplasia Testing Market Size Market Share by Type (2014-2019)
Table Global Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Size Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia Testing Market Size Market Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application in 2018
Figure United States Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table United States Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table United States Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table United States Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table United States Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table United States Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table United States Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure Europe Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table Europe Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table Europe Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table Europe Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Europe Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table Europe Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Europe Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure China Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table China Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table China Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table China Benign Prostatic Hyperplasia Testing Market Size by Type (2014-20189) (Million US$)
Table China Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table China Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table China Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure Japan Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table Japan Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table Japan Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table Japan Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Japan Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table Japan Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Japan Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure Southeast Asia Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure India Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table India Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table India Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table India Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table India Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table India Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table India Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure Central & South America Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table Central & South America Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Central & South America Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table Central & South America Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Central & South America Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Table AEternaZentaris Company Details
Table AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019) (Million US$)
Figure AEternaZentaris Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table AEternaZentaris Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Astellas Pharma Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table IntelGenx Technologies Corp Company Details
Table IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure IntelGenx Technologies Corp Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table IntelGenx Technologies Corp Recent Development
Table Nymox Pharmaceutical Corporation Company Details
Table Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Nymox Pharmaceutical Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Nymox Pharmaceutical Corporation Recent Development
Table Protox Therapeutics Company Details
Table Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Protox Therapeutics Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Protox Therapeutics Recent Development
Table Quest PharmaTech Company Details
Table Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Quest PharmaTech Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Quest PharmaTech Recent Development
Table Global Benign Prostatic Hyperplasia Testing Market Size by Regions (Million US$) 2019-2025
Figure Global Benign Prostatic Hyperplasia Testing Market Size Share by Regions (2019-2025)
Figure Global Benign Prostatic Hyperplasia Testing Market Size Share by Regions in 2025
Figure United States Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure China Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure India Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Table Global Benign Prostatic Hyperplasia Testing Market Size by Product (2019-2025) (Million US$)
Figure Global Benign Prostatic Hyperplasia Testing Market Size by Product (2019-2025)
Figure Global Benign Prostatic Hyperplasia Testing Market Size by Product in 2025
Table Global Benign Prostatic Hyperplasia Testing Market Size by Application (2019-2025) (Million US$)
Figure Global Benign Prostatic Hyperplasia Testing Market Size by Application (2019-2025)
Figure Global Benign Prostatic Hyperplasia Testing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources